Back

Prognostic Impact of the Combined Effect of Lipoprotein(a) and Homocysteine in Patients with Premature Myocardial Infarction: a Prospective Cohort Study

30 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers in acute coronary syndromes (3) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Jing Gao

Tianjin Chest Hospital, Tianjin (China)

6 More presentations in this session

Presentation thumbnail
Association of free fatty acids with long-term adverse outcomes in patients with premature myocardial infarction: a prospective cohort study
Professor J. Gao (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Plasma proteomics based sub-phenotypes in coronary artery disease are related to plaque characteristics and clinical outcome
Doctor J. Veiga-Fernandes Mira (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Comparison of generation 6 and generation 5 high-sensitivity cardiac troponin T assays in the early diagnosis of myocardial infarction
Doctor L. Koechlin (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of clonal haematopoiesis of indeterminate potential-mutations with inflammation biomarkers in patients with STEMI
Doctor X. Zhao (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Hemoglobin and long-term risk of death in patients with acute myocardial infarction
Doctor M. Todorovic Markovic (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in acute coronary syndromes (3)

The Event

Event poster

ESC Congress 2025

30 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Combined effect of lipoprotein(a) and C-reactive protein on future cardiovascular outcomes after acute myocardial infarction
thumbnail
Congress Presentation
Impact of lipoprotein A on long-term outcomes in acute coronary syndrome: a retrospective cohort analysis
thumbnail
Congress Session
Comorbidities and prognosis in chronic coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources